Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials

Autor: Rothwell, PM, Cook, NR, Gaziano, JM, Price, JF, Belch, JFF, Roncaglioni, MC, Morimoto, T, Mehta, Z

Publikováno v: Rothwell, P M, Cook, N R, Gaziano, J M, Price, J F, Belch, J F F, Roncaglioni, M C, Morimoto, T & Mehta, Z 2018, ' Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials ', The Lancet, vol. 392, no. 10145, pp. 387-399 . https://doi.org/10.1016/S0140-6736(18)31133-4

Background A one-dose-fits-all approach to use of aspirin has yielded only modest benefits in long-term prevention of cardiovascular events, possibly due to underdosing in patients of large body size and excess dosing in patients of small body size,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d831b5b28deb26a200b250966f67bb8a
https://hdl.handle.net/20.500.11820/f4efbd1e-5c42-4b87-800d-affbb8b377bb

Cognitive function, disease burden and the structural connectome in systemic lupus erythematosus.

Autor: Wiseman SJ; 1 Centre for Clinical Brain Sciences, University of Edinburgh, UK., Bastin ME; 1 Centre for Clinical Brain Sciences, University of Edinburgh, UK., Amft EN; 2 Department of Rheumatology, Western General Hospital, Edinburgh, UK., Belch JFF; 3 Division of Cardiovascular and Diabetes Medicine, University of Dundee, UK., Ralston SH; 4 Centre for Genomic and Experimental Medicine, University of Edinburgh, UK., Wardlaw JM; 1 Centre for Clinical Brain Sciences, University of Edinburgh, UK.

Publikováno v: Lupus [Lupus] 2018 Jul; Vol. 27 (8), pp. 1329-1337. Date of Electronic Publication: 2018 May 03.